These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 17311601)

  • 21. Treatment of irritable bowel syndrome.
    Hadley SK; Gaarder SM
    Am Fam Physician; 2005 Dec; 72(12):2501-6. PubMed ID: 16370407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatigue in irritable bowel syndrome: characterization and putative role of leptin.
    Piche T; Huet PM; Gelsi E; Barjoan EM; Cherick F; Caroli-Bosc FX; Hébuterne X; Tran A
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):237-43. PubMed ID: 17301651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms.
    Dughera L; Elia C; Navino M; Cisarò F;
    Acta Biomed; 2007 Aug; 78(2):111-6. PubMed ID: 17933278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sympathetic (electrodermal) activity during repeated maximal rectal distensions in patients with irritable bowel syndrome and constipation.
    Walter S; Bodemar G; Hallböök O; Thorell LH
    Neurogastroenterol Motil; 2008 Jan; 20(1):43-52. PubMed ID: 17919314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy of four fecal assays in the diagnosis of colitis.
    Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F
    Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for intestinal ischaemia among patients registered in a UK primary care database: a nested case-control study.
    Huerta C; Rivero E; Montoro MA; García-Rodriguez LA
    Aliment Pharmacol Ther; 2011 Apr; 33(8):969-78. PubMed ID: 21366637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spasmocanulase in irritable bowel syndrome.
    Mohamed AE; Ghandour ZM; Al-Karawi MA
    Saudi Med J; 2002 Sep; 23(9):1074-7. PubMed ID: 12370715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial.
    Cappello G; Spezzaferro M; Grossi L; Manzoli L; Marzio L
    Dig Liver Dis; 2007 Jun; 39(6):530-6. PubMed ID: 17420159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of irritable bowel syndrome among undergraduates in Southeast China.
    Dai N; Cong Y; Yuan H
    Dig Liver Dis; 2008 Jun; 40(6):418-24. PubMed ID: 18339591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gallstones, cholecystectomy and irritable bowel syndrome (IBS) MICOL population-based study.
    Corazziari E; Attili AF; Angeletti C; De Santis A
    Dig Liver Dis; 2008 Dec; 40(12):944-50. PubMed ID: 18406218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficiency of autogenous training in medical rehabilitation of patients with irritable colon syndrome with constipation dominance].
    Pakhomova IV; Aĭvazian TA; Zaĭtsev VP; Gusakova EV; Molina LP
    Vopr Kurortol Fizioter Lech Fiz Kult; 2008; (1):24-7. PubMed ID: 18376480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of gluten-free diet and co-morbidity of irritable bowel syndrome-type symptoms on health-related quality of life in adult coeliac patients.
    Usai P; Manca R; Cuomo R; Lai MA; Boi MF
    Dig Liver Dis; 2007 Sep; 39(9):824-8. PubMed ID: 17644056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome.
    Ringel Y; Williams RE; Kalilani L; Cook SF
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):68-72; quiz 3. PubMed ID: 19124113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunological profile of coeliac disease in a subgroup of patients with symptoms of irritable bowel syndrome].
    Elloumi H; El Assoued Y; Ghédira I; Ben Abdelaziz A; Yacoobi MT; Ajmi S
    Tunis Med; 2008 Sep; 86(9):802-5. PubMed ID: 19472779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome.
    Harish K; Hazeena K; Thomas V; Kumar S; Jose T; Narayanan P
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1183-9. PubMed ID: 17688659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].
    Moskwa A; Chojnacki J; Wiśiewska-Jarosińska M; Stec-Michalska K; Szadkowski K; Smigielski J; Chojnacki C
    Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ischemic colitis, irritable bowel syndrome, and tegaserod--an alternative viewpoint.
    Shetzline MA; Cohard-Radice M; Joelsson B
    Pharmacotherapy; 2005 Nov; 25(11):1684-5; discussion 1685. PubMed ID: 16232032
    [No Abstract]   [Full Text] [Related]  

  • 38. Significant psychological morbidity occurs in irritable bowel syndrome: a case-control study using a pharmacy reimbursement database.
    Canavan JB; Bennett K; Feely J; O'Moráin CA; O'Connor HJ
    Aliment Pharmacol Ther; 2009 Feb; 29(4):440-9. PubMed ID: 19035966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.
    Chey WD; Paré P; Viegas A; Ligozio G; Shetzline MA
    Am J Gastroenterol; 2008 May; 103(5):1217-25. PubMed ID: 18477346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anger and ego-defence mechanisms in non-psychiatric patients with irritable bowel syndrome.
    Zoccali R; Muscatello MR; Bruno A; Barillà G; Campolo D; Meduri M; Familiari L; Bonica M; Consolo P; Scaffidi M
    Dig Liver Dis; 2006 Mar; 38(3):195-200. PubMed ID: 16500602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.